• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Information Technology Stocks Moving In Friday's After-Market Session

    1/26/24 4:30:57 PM ET
    $AKTS
    $BTOG
    $CYN
    $EMKR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $AKTS alert in real time by email

    Gainers

    • EMCORE (NASDAQ:EMKR) shares rose 8.0% to $0.68 during Friday's after-market session. The market value of their outstanding shares is at $52.6 million.
    • SPI Energy (NASDAQ:SPI) stock increased by 5.85% to $0.64. The company's market cap stands at $20.0 million.
    • Akerna (NASDAQ:KERN) stock moved upwards by 4.66% to $0.33. The company's market cap stands at $3.4 million.
    • Remark Hldgs (NASDAQ:MARK) stock rose 3.6% to $0.37. The market value of their outstanding shares is at $7.7 million.
    • Baijiayun Group (NASDAQ:RTC) shares moved upwards by 3.38% to $6.1. The company's market cap stands at $534.9 million.
    • Quantum (NASDAQ:QMCO) stock moved upwards by 3.33% to $0.37. The market value of their outstanding shares is at $35.0 million.

    Losers

    • SMX (Security Matters) (NASDAQ:SMX) shares fell 18.6% to $0.35 during Friday's after-market session. The market value of their outstanding shares is at $2.1 million.
    • Bit Origin (NASDAQ:BTOG) shares declined by 6.12% to $4.45. The market value of their outstanding shares is at $24.6 million.
    • Cyngn (NASDAQ:CYN) stock decreased by 6.06% to $0.25. The market value of their outstanding shares is at $13.3 million.
    • Nvni Group (NASDAQ:NVNI) shares fell 5.12% to $2.78. The market value of their outstanding shares is at $78.9 million.
    • CCSC Technology (NASDAQ:CCTG) shares declined by 4.98% to $18.51. The company's market cap stands at $210.5 million.
    • Akoustis Technologies (NASDAQ:AKTS) shares declined by 4.7% to $0.52. The company's market cap stands at $39.3 million. See Also: www.benzinga.com/money/tech-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $BTOG
    $CYN
    $EMKR

    CompanyDatePrice TargetRatingAnalyst
    Quantum Corporation
    $QMCO
    3/25/2026$8.00Buy
    Lake Street
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    Quantum Corporation
    $QMCO
    11/14/2025Market Perform → Outperform
    Northland Capital
    EMCORE Corporation
    $EMKR
    10/2/2024$3.00Hold → Buy
    Craig Hallum
    More analyst ratings

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Quantum with a new price target

    Lake Street resumed coverage of Quantum with a rating of Buy and set a new price target of $8.00

    3/25/26 8:49:51 AM ET
    $QMCO
    Electronic Components
    Technology

    H.C. Wainwright initiated coverage on Aktis Oncology with a new price target

    H.C. Wainwright initiated coverage of Aktis Oncology with a rating of Buy and set a new price target of $30.00

    3/9/26 9:06:39 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analyst initiated coverage on Aktis Oncology with a new price target

    Analyst initiated coverage of Aktis Oncology with a rating of Overweight and set a new price target of $30.00

    2/3/26 6:54:43 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gormley Glenn

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:15:09 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Gormley Glenn

    3 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:05:08 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Nash Laura A.

    4 - QUANTUM CORP /DE/ (0000709283) (Issuer)

    4/3/26 4:15:38 PM ET
    $QMCO
    Electronic Components
    Technology

    $AKTS
    $BTOG
    $CYN
    $EMKR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cyngn Inc.

    SCHEDULE 13G - Cyngn Inc. (0001874097) (Subject)

    4/22/26 9:01:55 AM ET
    $CYN
    EDP Services
    Technology

    SEC Form 8-K filed by Aktis Oncology Inc.

    8-K - Aktis Oncology, Inc. (0002035832) (Filer)

    4/16/26 4:01:24 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Bit Origin Limited

    6-K - BIT ORIGIN Ltd (0001735556) (Filer)

    4/16/26 9:00:21 AM ET
    $BTOG
    Finance: Consumer Services
    Finance

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Quantum CatDV Showcases Automated Live Sports Production with North Shore Automation's Stats Injector

    Integration delivers real-time play-by-play metadata directly into media assets for professional sports organizations; Continues recent platform enhancements including expanded cloud, clustering, and AI capabilities Quantum Corporation (NASDAQ:QMCO) today announced that North Shore Automation's Stats Injector is now fully compatible with Quantum CatDV, the media asset management and workflow orchestration platform used by broadcasters, sports leagues, and post-production teams world-wide, bringing automated, data-driven clip logging to live sports production workflows. The integration, already deployed in production with the Miami HEAT, is designed to pull hyper-accurate play-by-play data

    4/17/26 10:49:00 AM ET
    $QMCO
    Electronic Components
    Technology

    Bit Origin Ltd Announces Strategic Financing to Explore Expansion into AI Computing and Data Center Services

    SINGAPORE, April 16, 2026 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ:BTOG) ("Bit Origin" or the "Company"), an emerging growth company focused on digital asset innovation and blockchain-based strategies, today announced that it has secured strategic financing to support the exploration of potential expansion into AI-driven computing, storage infrastructure and cooling services. The Company intends to utilize available resources to evaluate, explore and potentially develop opportunities in the leasing, management and optimization of AI computing, storage infrastructure and cooling services, including GPU-based computing resources and related server systems. The global demand for computing

    4/16/26 9:00:00 AM ET
    $BTOG
    Finance: Consumer Services
    Finance

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:17:54 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Leadership Updates

    Live Leadership Updates

    View All

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuvini Appoints Phoebe Wang as Chief AI Officer

    NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Nuvini Group Limited (NASDAQ:NVNI) ("Nuvini" or the "Company"), a leading acquirer and operator of profitable B2B SaaS businesses across America and emerging markets, today announced the appointment of Phoebe Wang as Chief Artificial Intelligence Officer ("CAIO"), effective March 2, 2026. Ms. Wang transitions from her role as a member of the Company's Board of Directors, where she has served since November 2025, to lead Nuvini's enterprise-wide AI strategy, investment, and implementation. Ms. Wang previously served as an Investment Partner on the Corporate Development team at Amazon, a leading artificial intelligence ("AI") technology company a

    3/2/26 8:47:00 AM ET
    $NVNI
    Computer Software: Prepackaged Software
    Technology

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Quantum Corporation

    SC 13G/A - QUANTUM CORP /DE/ (0000709283) (Subject)

    12/4/24 12:24:18 PM ET
    $QMCO
    Electronic Components
    Technology

    SEC Form SC 13G filed by EMCORE Corporation

    SC 13G - EMCORE CORP (0000808326) (Subject)

    11/18/24 4:55:14 PM ET
    $EMKR
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by EMCORE Corporation

    SC 13G/A - EMCORE CORP (0000808326) (Subject)

    11/14/24 1:15:57 PM ET
    $EMKR
    Semiconductors
    Technology

    $AKTS
    $BTOG
    $CYN
    $EMKR
    Financials

    Live finance-specific insights

    View All

    Cyngn Announces Date for 2025 Fourth Quarter and Year-End Financial Results

    MOUNTAIN VIEW, Calif., March 5, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) will announce its 2025 fourth quarter and year-end financial results for the period ended December 31, 2025, on Wednesday, March 25, 2026, after the close of market. The financial results will be available on the Cyngn website under "News & Events" at https://investors.cyngn.com/.  The Company will not host an earnings call.About CyngnCyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges f

    3/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Quantum Reports Fiscal Third Quarter 2026 Financial Results

    Quantum Corporation (NASDAQ:QMCO) ("Quantum" or the "Company"), today announced financial results for its fiscal third quarter of 2026 ended December 31, 2025. Fiscal Third Quarter 2026 Financial Summary Revenue was $74.6 million, exceeding the preliminary revenue results of $72.7 million and the original guidance range of $67 million, plus or minus $2.0 million Higher than expected revenue was primarily driven by strong shipments into quarter-end, and to a lesser extent, conservative assumptions related to deferred revenue contracts GAAP operating expenses were $30.1 million; non-GAAP adjusted operating expenses were $26.9 million, reflecting a year-over-year reduction of over $

    2/17/26 4:05:00 PM ET
    $QMCO
    Electronic Components
    Technology

    Quantum to Announce Fiscal Third Quarter 2026 Financial Results on February 17, 2026

    Quantum Corporation (NASDAQ:QMCO) ("Quantum" or the "Company"), today announced it will release financial results for its fiscal third quarter 2026 on Tuesday, February 17, 2026, after the markets close. Hugues Meyrath, Chief Executive Officer, and William White, Chief Financial Officer, will host a conference call on Tuesday, February 17, 2026 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the Company's financial results and business outlook. Analysts and investors are invited to join the conference call using the following information: Date: Tuesday, February 17, 2026 Time: 5:00 p.m. ET (2:00 p.m. PT) Conference Call Number: 1-866-424-3436 International Call Number: +

    2/9/26 4:05:00 PM ET
    $QMCO
    Electronic Components
    Technology